Dolphin Medical ServicesBOM:526504 36 Gross Margin % is 88.28% as of Mar. 2026, which is 4% above its 10-year median of 85.09. GuruFocus rates BOM:526504 with a GF Score™ of 36/100 and a GF Value™ of ₹2.38 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 194 Medical Diagnostics & Research companies, Dolphin Medical Services ranks better than 93.81% on this metric.
BOM:526504's Gross Margin % is ranked better than 93.81% of 194
companies
in the Medical Diagnostics & Research industry
Industry Median: 50.45
vs BOM:526504: 86.82
Dolphin Medical Services had a gross margin of 88.28% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Dolphin Medical Services was -0.80% per year.
Dolphin Medical Services (BOM:526504) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Dolphin Medical Services had a gross margin of 88.28% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Dolphin Medical Services Gross Margin % Related Terms
Dolphin Medical Services Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:526504 vs TMO, DHR, IDXX: Gross Margin % Comparison
For the Diagnostics & Research subindustry, Dolphin Medical Services's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dolphin Medical Services Gross Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Dolphin Medical Services's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Dolphin Medical Services's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Dolphin Medical Services (BOM:526504) has a Gross Margin % of 88.28% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Dolphin Medical Services and its competitors. This is near median its historical median of 85.09. Over the past decade, Dolphin Medical Services' Gross Margin % has ranged from 63.33 to 91.21. According to the industry distribution chart, Dolphin Medical Services ranks #12 out of 194 companies in the Medical Diagnostics & Research industry, placing it in the top 6.2%.
Is Dolphin Medical Services' Gross Margin % too high?
Dolphin Medical Services' current Gross Margin % of 88.28% is near median its 10-year median of 85.09. Over the past 10 years, this metric has ranged from a low of 63.33 to a high of 91.21. The Medical Diagnostics & Research industry median Gross Margin % is 50.45. Dolphin Medical Services' value of 88.28% is 75% above this industry median. Based on the distribution chart, Dolphin Medical Services ranks #12 out of 194 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Dolphin Medical Services has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dolphin Medical Services' Gross Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Dolphin Medical Services ranks #12 out of 194 companies for Gross Margin %. This places Dolphin Medical Services in the top 6% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 50.45. Dolphin Medical Services' value of 88.28% is 75% above this benchmark. Historically, Dolphin Medical Services' own Gross Margin % has ranged from 63.33 to 91.21 over the past decade. While the company's 10-year median is 85.09 vs. the industry median of 50.45, Dolphin Medical Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Diagnostics & Research company?
The median Gross Margin % among Medical Diagnostics & Research companies is 50.45, based on 194 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dolphin Medical Services's current Gross Margin % of 88.28% is 75% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Dolphin Medical Services and its competitors. For the Medical Diagnostics & Research industry, the median Gross Margin % is 50.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dolphin Medical Services's current Gross Margin % is 88.28%, which is near median its own 10-year median of 85.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dolphin Medical Services stock overvalued right now?
Based on GuruFocus' analysis, Dolphin Medical Services (BOM:526504) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹2.38, compared to a current price of ₹9.12 — trading 283.2% above its estimated fair value. The current Gross Margin % is 88.28%, which is near median its 10-year median of 85.09 and 75% above the Medical Diagnostics & Research industry median of 50.45. Dolphin Medical Services' overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Dolphin Medical Services (BOM:526504), the current Gross Margin % is 88.28% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dolphin Medical Services (BOM:526504) Overvalued in 2026?
Based on GuruFocus' analysis, Dolphin Medical Services stock appears to be overvalued.
The current stock price of ₹9.12 is trading 283.2% above its estimated GF Value™ of ₹2.38.
GuruFocus considers Dolphin Medical Services to be Significantly Overvalued.
Key valuation signals for BOM:526504:
Gross Margin %: 88.28% (near median its 10-year median of 85.09)
GF Value™: ₹2.38 vs. price of ₹9.12 (283.2% above fair value)
Industry Position: 75% above the Medical Diagnostics & Research median (#12 of 194)
No single metric tells the full story. See the BOM:526504 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dolphin Medical Services Ltd is engaged in providing diagnostics and other allied services. It includes a range of tests covering radiology and imaging, biochemistry, pathology, and microbiology. In addition, the company is also involved in Information Technology, Biotechnology, and Herbal sectors. Services provided by the company are Diagnostic Centre provides all the services under one roof; the Ophthalmic Laser Care Centre provides total laser eye treatment as "Dolphin Nethralaya"; Teleradiology Services; Clinical Trials and Life Sciences division; Medical Equipment & Goods associated distribution; Bio-Tech Division is to provide Foods and Herbal Products and Dolphin Electronic Solution and Technologies(DEST).
36GF Score
Get the complete analysis for BOM:526504
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:526504 has been successfully added to your 
